论文部分内容阅读
目的:针对血清降钙素原水平对慢性阻塞性肺疾病急性加重期抗生素使用的指导价值加以评价分析。方法:抽取2014年8月至2016年1月在本院接受治疗的72例慢性阻塞性肺疾病急性加重期患者,随机分成观察者和对照组,各36例,其中对照组结合治疗经验给用抗生素,观察组结合患者血清降钙素原水平给予抗生素治疗,对两组指导价值加以观察。结果:观察组的住院时间、住院费用、抗菌药物疗程、二重感染率以及抗生素使用费用明显优先于对照组(P<0.05)。结论:结合血清降钙素原水平,采取抗生素治疗慢性阻塞性肺疾病急性加重期患者,安全性高,治疗效果明显,值得在临床医学上的推广使用。
OBJECTIVE: To evaluate the value of serum procalcitonin in guiding the use of antibiotics in acute exacerbation of chronic obstructive pulmonary disease. Methods: Seventy-two patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) treated in our hospital from August 2014 to January 2016 were randomly divided into observation group and control group, with 36 cases in each group, of which the control group combined with the treatment experience Antibiotics, the observation group combined with serum procalcitonin levels of patients given antibiotic treatment, the two groups to observe the guiding value. Results: The length of stay, cost of hospitalization, course of antimicrobial treatment, rate of double infection and cost of antibiotics in observation group were significantly higher than those in control group (P <0.05). Conclusion: Combined with serum procalcitonin levels, taking antibiotics in patients with acute exacerbation of chronic obstructive pulmonary disease, high safety, the treatment effect is obvious, it is worth in the clinical use of medicine.